Lupin shares touch 52-week high as Q1 profit surges 77%
Lupin deals in branded and generic formulations, active pharmaceutical ingredients (APIs), and biosimilars.
Lupin deals in branded and generic formulations, active pharmaceutical ingredients (APIs), and biosimilars.
Lupin Pharmaceuticals Inc., the U.S. arm of the drug major, is voluntarily recalling four lots of Quinapril Tablets due to the presence of nitrosamine impurity.
Lupin has received U.S. FDA approval for Mirabegron Extended-Release Tablets used for the treatment of overactive bladder.